Vol. 8 No. 1
March 1998

Insuring Quality Community Healthcare

Winthrop's Advance Directive Initiative

The Winthrop South Nassau University Health System Opens Homecare*America Superstore in Mineola

Winthrop Welcomes Three New Directors

Winthrop Opens a Second, Fully Monitored Neurosurgical Intermediate Care Unit

Winthrop's $12 Million New Life Center is on Track for July, l998

Winthrop's Long Island Regional Poison Control Center Observes Fifth Anniversary of Averting Danger, Saving Lives

Patient Unit is Dedicated to the Management of Chronic Obstructive Pulmonary Disease

Long Island's First Dual Chamber Defibrillator is Implanted in Winthrop's Electrophysiology Lab

Report from The Heart Institute at Winthrop: Third Cardiac Catheterization Lab is Authorized by State Department of Health

Winthrop's Artificial Heart Device Program: A Revolutionary Treatment for End-Stage Heart Disease Patients

Winthrop's Dialysis Centers Receive National Award for Patient Encouragement - One of Only Six Programs in the United States to be Recognized

Endoscopic Ultrasound: On The Forefront of Technology

Long Island Chapter of Impotents Anonymous Meets at Winthrop, Filling an Intimate Need ---Confidentially

Winthrop's Stem Cell Autologous Transplantation Therapy Program Saves a Life - And Can Save More!

Winthrop Adds Powerful New Radiological Intervention

Winthrop Auxilians Donate Service, Talent, and Creative Fundraising

Winthrop's Division of Reproductive Medicine Makes Parenthood Possible

Dialysis is technology...but caring is an art.

Back to Publications

Twenty to 30 million men in the United States suffer from chronic erectile dysfunction, which may deeply affect the men, their spouses or partners, and their intimate relationship.

As the Medical Advisor to the Long Island Chapter of Impotents Anonymous (IA), Brett C. Mellinger, MD, Chairman of the Department of Urology at Winthrop, urges concerned men and their partners throughout the Metropolitan area to attend the monthly IA meetings at Winthrop, where critical information on the newest approaches to the treatment of erectile dysfunction is presented.

"Impotents Anonymous is a completely confidential self-help group for men who suffer from chronic erectile dysfunction, as well as their partners," Dr. Mellinger explains. The Long Island Chapter of Impotents Anonymous, part of a national organization, is the only such group serving this need in Nassau, Suffolk, and Queens. IA is a forum for the community, providing reliable facts on the causes and available medical treatments for male impotence, with an opportunity to question professionals. Through IA, many men have availed themselves of treatments enabling the resumption of healthy sexual function.

IA meetings focus on the newest pharmaceutical approaches to chronic erectile dysfunction, with discussions about related psychological issues. Dr. Mellinger is ably assisted in program planning and presentation by Pamela Schrock, PhD, Director of Psychotherapeutic and Sexual Health with Winthrop's Department of Ob/Gyn, and Sheldon Bloom, IA Coordinator.

"Ninety percent of erectile dysfunction has a physical basis," says Dr. Mellinger, identifying diabetes and prostate cancer as two frequent causes. Any condition causing a vascular problem can result in impotence, including elevated cholesterol levels. Even smoking can be problematic. Spinal and pelvic surgical procedures, and resection for bowel cancer, can also be detrimental to erections, as can neurological conditions such as Parkinson's Disease, Multiple Sclerosis, and spinal cord injuries.

A recent program featured a representative from Pharmacia & Upjohn, manufacturer of Caverject, the first FDA-approved penile injectable drug to be proven safe and effective for organic erectile dysfunction.

Another meeting presented a representative from Vivus, Inc., maker of MUSE, an FDA-approved treatment, similar pharmaceutically to Caverject, which utilizes a urethral suppository to induce penile erection by increasing blood flow - an alternative for men who are uncomfortable with penile self-injection therapy. A third therapy - a vacuum constriction device made by Mission Pharmacal - has been discussed. Dr. Mellinger also led a recent program on "The Pill for Impotence is Coming: Just How Good Is It?"

Each meeting explores therapies, alternatives, and outcomes in down-to-earth language - with sensitivity and the utmost confidentiality. Approximately six new members join IA each month, says Dr. Mellinger, who welcomes your inquiries at 516/663-2305.

[ Home | Search | Contact | Directions | Privacy Notice ]

Winthrop-University Hospital | 259 First Street | Mineola NY 11501 | 516-663-0333

This site provides information as a resource. It is not a substitute for professional medical advice.
Always consult a physician or healthcare provider for treatment and guidance toward good health.
Copyright © 2008 Winthrop-University Hospital. All rights reserved. Long Island Web Design